BioSpace News Archive

Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife® and Radixact® System software innovations were shared by prominent physicists at the recent 61st annual meeting of the American Association of Physicists in Medicine (AAPM).

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on August 5, 2019, at 4:30 p.m. EDT to discuss its financial results for the fiscal 2019 third quarter ended June 30, 2019.

Mike Wattenbarger Named Senior Vice President of Information Technology

One of the nation’s most successful life sciences incubators forms internal investment program to provide seed and early-stage funding for its companies

Disruptive Autonomous Surgical System Implements oVio’s Revolutionary Imaging Technology

Appoints pharmaceutical industry veteran Richard N. Kender, MBA, and life sciences financing professional Janice Bourque, MBA

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) (“DelMar” or the “Company”), today announces that the first patient has been treated in the adjuvant (pre-temozolomide maintenance) trial arm of VAL-083’s Phase 2 study in MGMT-unmethylated glioblastoma multiforme (GBM) being conducted at the University of Texas MD Anderson Cancer Center (MDACC)

As of June 30, 2019, Odonate had $206.9 million in cash, compared to $139.1 million as of December 31, 2018.

The global organic banana market is expected to post a CAGR close to 11% during the period 2019-2023, according to the latest market research report by Technavio.

UNC School of Medicine researchers identify anorexia nervosa genetic variants, redefine disorder as metabolic and psychiatric